Inclusion of Endogenous Plasma Dehydroepiandrosterone Sulfate and Mammographic Density in Risk Prediction Models for Breast Cancer
- PMID: 31948996
- DOI: 10.1158/1055-9965.EPI-19-1120
Inclusion of Endogenous Plasma Dehydroepiandrosterone Sulfate and Mammographic Density in Risk Prediction Models for Breast Cancer
Abstract
Background: Endogenous hormones and mammographic density are risk factors for breast cancer. Joint analyses of the two may improve the ability to identify high-risk women.
Methods: This study within the KARMA cohort included prediagnostic measures of plasma hormone levels of dehydroepiandrosterone (DHEA), its sulfate (DHEAS), and mammographic density in 629 cases and 1,223 controls, not using menopausal hormones. We evaluated the area under the receiver-operating curve (AUC) for risk of breast cancer by adding DHEA, DHEAS, and mammographic density to the Gail or Tyrer-Cuzick 5-year risk scores or the CAD2Y 2-year risk score.
Results: DHEAS and percentage density were independently and positively associated with breast cancer risk (P = 0.007 and P < 0.001, respectively) for postmenopausal, but not premenopausal, women. No significant association was seen for DHEA. In postmenopausal women, those in the highest tertiles of both DHEAS and density were at greatest risk of breast cancer (OR, 3.5; 95% confidence interval, 1.9-6.3) compared with the lowest tertiles. Adding DHEAS significantly improved the AUC for the Gail (+2.1 units, P = 0.008) and Tyrer-Cuzick (+1.3 units, P = 0.007) risk models. Adding DHEAS to the Gail and Tyrer-Cuzick models already including mammographic density further increased the AUC by 1.2 units (P = 0.006) and 0.4 units (P = 0.007), respectively, compared with only including density.
Conclusions: DHEAS and mammographic density are independent risk factors for breast cancer and improve risk discrimination for postmenopausal breast cancer.
Impact: Combining DHEAS and mammographic density could help identify women at high risk who may benefit from individualized breast cancer screening and/or preventive measures among postmenopausal women.
©2020 American Association for Cancer Research.
Similar articles
-
Addition of a polygenic risk score, mammographic density, and endogenous hormones to existing breast cancer risk prediction models: A nested case-control study.PLoS Med. 2018 Sep 4;15(9):e1002644. doi: 10.1371/journal.pmed.1002644. eCollection 2018 Sep. PLoS Med. 2018. PMID: 30180161 Free PMC article.
-
Inclusion of endogenous hormone levels in risk prediction models of postmenopausal breast cancer.J Clin Oncol. 2014 Oct 1;32(28):3111-7. doi: 10.1200/JCO.2014.56.1068. Epub 2014 Aug 18. J Clin Oncol. 2014. PMID: 25135988 Free PMC article.
-
Mammographic density adds accuracy to both the Tyrer-Cuzick and Gail breast cancer risk models in a prospective UK screening cohort.Breast Cancer Res. 2015 Dec 1;17(1):147. doi: 10.1186/s13058-015-0653-5. Breast Cancer Res. 2015. PMID: 26627479 Free PMC article.
-
Improvement in risk prediction, early detection and prevention of breast cancer in the NHS Breast Screening Programme and family history clinics: a dual cohort study.Southampton (UK): NIHR Journals Library; 2016 Aug. Southampton (UK): NIHR Journals Library; 2016 Aug. PMID: 27559559 Free Books & Documents. Review.
-
Beyond Breast Density: Risk Measures for Breast Cancer in Multiple Imaging Modalities.Radiology. 2023 Mar;306(3):e222575. doi: 10.1148/radiol.222575. Epub 2023 Feb 7. Radiology. 2023. PMID: 36749212 Free PMC article. Review.
Cited by
-
Circulating proteins reveal prior use of menopausal hormonal therapy and increased risk of breast cancer.Transl Oncol. 2022 Mar;17:101339. doi: 10.1016/j.tranon.2022.101339. Epub 2022 Jan 13. Transl Oncol. 2022. PMID: 35033985 Free PMC article.
-
Hormonal determinants of mammographic density and density change.Breast Cancer Res. 2020 Aug 26;22(1):95. doi: 10.1186/s13058-020-01332-4. Breast Cancer Res. 2020. PMID: 32847607 Free PMC article.
-
Cancer Progress and Priorities: Breast Cancer.Cancer Epidemiol Biomarkers Prev. 2021 May;30(5):822-844. doi: 10.1158/1055-9965.EPI-20-1193. Cancer Epidemiol Biomarkers Prev. 2021. PMID: 33947744 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical